Etirinotecan Pegol
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Etirinotecan Pegol, covering 2019-09-10 to 2021-08-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine [Phase 3]